Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - AMAG PHARMACEUTICALS, INC. | ex3222019.htm |
| EX-32.1 - EXHIBIT 32.1 - AMAG PHARMACEUTICALS, INC. | ex3212019.htm |
| EX-31.2 - EXHIBIT 31.2 - AMAG PHARMACEUTICALS, INC. | ex3122019.htm |
| EX-31.1 - EXHIBIT 31.1 - AMAG PHARMACEUTICALS, INC. | ex3112019.htm |
| EX-21.1 - EXHIBIT 21.1 - AMAG PHARMACEUTICALS, INC. | ex2112019.htm |
| EX-10.24 - EXHIBIT 10.24 - AMAG PHARMACEUTICALS, INC. | ex10242019.htm |
| EX-10.20 - EXHIBIT 10.20 - AMAG PHARMACEUTICALS, INC. | ex10202019.htm |
| EX-10.15 - EXHIBIT 10.15 - AMAG PHARMACEUTICALS, INC. | ex10152019.htm |
| EX-10.14 - EXHIBIT 10.14 - AMAG PHARMACEUTICALS, INC. | ex10142019.htm |
| EX-10.13 - EXHIBIT 10.13 - AMAG PHARMACEUTICALS, INC. | ex10132019.htm |
| EX-10.12 - EXHIBIT 10.12 - AMAG PHARMACEUTICALS, INC. | ex10122019.htm |
| EX-10.11 - EXHIBIT 10.11 - AMAG PHARMACEUTICALS, INC. | ex10112019.htm |
| EX-10.10 - EXHIBIT 10.10 - AMAG PHARMACEUTICALS, INC. | ex10102019.htm |
| EX-4.8 - EXHIBIT 4.8 - AMAG PHARMACEUTICALS, INC. | ex482019.htm |
| 10-K - 10-K - AMAG PHARMACEUTICALS, INC. | a201910-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (File No. 333-225604) and on Forms S‑8 (File Nos. 333‑148682, 333‑159938, 333‑168786, 333-182821, 333‑190435, 333‑197873, 333-203924, 333-211277, 333-218911, 333-226548 and 333-231542) of AMAG Pharmaceuticals, Inc. of our report dated March 6, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP | |
Boston, Massachusetts | |
March 6, 2020 | |